Melanocortin receptor-mediated effects on obesity are distributed over specific hypothalamic regions
Authors:
- S E la FleurSFS E la Fleur
- M A D BransMBM A D Brans
- A J van RozenARA J van Rozen
- M C M LuijendijkMLM C M Luijendijk
- M MerkesteinMMM Merkestein
- K M GarnerKGK M Garner
- E M van der ZwaalEZE M van der Zwaal
- R A H AdanRAR A H Adan
- 24 August 2010
- journal article
- Published by Springer Nature in International Journal of Obesity
- Vol. 35 (5) , 629-641
Abstract
Reduction of melanocortin signaling in the brain results in obesity. However, where in the brain reduced melanocortin signaling mediates this effect is poorly understood. We determined the effects of long-term inhibition of melanocortin receptor activity in specific brain regions of the rat brain. Melanocortin signaling was inhibited by injection of a recombinant adeno-associated viral (rAAV) vector that overexpressed Agouti-related peptide (AgRP) into the paraventricular nucleus (PVN), the ventromedial hypothalamus (VMH), the lateral hypothalamus (LH) or the accumbens shell (Acc). Overexpression of AgRP in the rat PVN, VMH or LH increased bodyweight, the percentage of white adipose tissue, plasma leptin and insulin concentrations and food intake. Food intake was mainly increased because of an increase in meal size in the light and dark phases, after overexpression of AgRP in the PVN, LH or VMH. Overexpression of AgRP in the PVN or VMH reduced average body core temperature in the dark on day 40 post injection, whereas AgRP overexpression in the LH did not affect temperature. In addition, overexpression of AgRP in the PVN, LH or VMH did not significantly alter mRNA expression of AgRP, neuropeptide Y (NPY), pro-opiomelanocortin (POMC) or suppressor of cytokine signaling 3 (SOCS3) in the arcuate. Overexpression of AgRP in the Acc did not have any effect on the measured parameters. Reduction of melanocortin signaling in several hypothalamic regions increased meal size. However, there were brain area-specific effects on other parameters such as core temperature and plasma leptin concentrations. In a previous study, where NPY was overexpressed with an rAAV vector in the PVN and LH, meal frequency and meal size were increased respectively, whereas locomotor activity was reduced by NPY overexpression at both nuclei. Taken together, AgRP and NPY have complementary roles in energy balance.Keywords
This publication has 59 references indexed in Scilit:
- Coordinated changes in energy intake and expenditure following hypothalamic administration of neuropeptides involved in energy balanceInternational Journal of Obesity, 2009
- Induction of Brain Region-Specific Forms of Obesity by AgoutiJournal of Neuroscience, 2004
- Chronic CNS administration of Agouti-related protein (Agrp) reduces energy expenditureInternational Journal of Obesity, 2003
- Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptorRegulatory Peptides, 2001
- AgRP(83–132) Acts as an Inverse Agonist on the Human-Melanocortin-4 ReceptorMolecular Endocrinology, 2001
- Role of the melanocortin-4 receptor in metabolic rate and food intake in miceTransgenic Research, 2000
- Overexpression of Agrt leads to obesity in transgenic miceNature Genetics, 1997
- Antagonism of Central Melanocortin Receptors in Vitro and in Vivo by Agouti-Related ProteinScience, 1997
- Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in MiceCell, 1997
- Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur.Proceedings of the National Academy of Sciences, 1995